ReviewAdvances in experimental medicine and biology2026
Inflammasomes in Oral Pathologies: From Periodontal Disease to Oral Cancer.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammasomes are multiprotein complexes that play a crucial role in the innate immune system, particularly in the regulation of inflammatory responses, and play a critical role in different oral pathologies, influencing the development and progression of conditions like periodontal disease and oral cancer by regulating inflammatory responses that contribute to tissue damage and tumorigenesis. The multiprotein inflammasome complexes have a role in the body's innate immune response by detecting pathogens, tissue damage, and other stress signals, leading to the activation of inflammatory cytokines, primarily interleukin-1β (IL-1β) and IL-18. In the context of periodontitis, a chronic inflammatory disease affecting the tissues supporting the teeth, inflammasomes are integral in mediating the inflammatory response that drives the disease progression. Their activation is pivotal in oral health and the progression of various oral diseases, ranging from periodontal diseases to oral cancer. This review explores the involvement of inflammasomes in oral pathologies, with a focus on their role in periodontal diseases, oral potentially malignant disorders (OPMDs), and oral cancer. Specifically, we examine how dysregulation of inflammasome activity contributes to inflammatory conditions like gingivitis and periodontitis, and how this can transition into more severe oral diseases, such as OPMDs and cancer. This chapter will also highlight the role of epigenetic changes in inflammasome regulation, providing insight into potential diagnostic and therapeutic strategies for oral health management. This comprehensive overview underscores the importance of inflammasome research in improving our understanding and treatment of oral pathologies, pointing to future directions for clinical applications.
Indexed as
Identifiers
41225105What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.